Literature DB >> 15087231

The interferon gamma secretion assay: a reliable tool to study interferon gamma production at the single cell level.

I Desombere1, P Meuleman, H Rigole, A Willems, J Irsch, G Leroux-Roels.   

Abstract

Different single-cell analyses for the detection of antigen-specific T cells based on antigen-triggered induction of cytokine production (elispot, intracellular cytokine staining, cytokine secretion assay, etc.) have been analyzed. In this paper we present the data of a thorough validation of the IFNgamma Secretion Assay (ISA, Miltenyi Biotec, Bergisch Gladbach, Germany). In this assay the secreted IFNgamma is bound to the cell surface and is then stained as an artificial surface molecule and analyzed by flow-cytometry. The introduction of five quality criteria markedly improved the reproducibility of this assay and made it very reliable (intra-assay variability<5%; inter-assay variability<20%). Recovery experiments further demonstrated that almost 100% of IFNgamma(+) labeled cells could be detected by this technology. In order to analyze which cell subsets contribute to IFNgamma-production, we compared the results obtained in different individuals after VZAg-stimulation. Three different IFNgamma-secretion patterns could be discerned. In Pattern 1 there is a predominant and almost equal contribution of T cells and NK cells with a minor contribution of CD3(+)CD56(+) and B cells. Pattern 2, which is most abundant, is characterized by a predominance of NK cells (60-70%). Pattern 3 differs from the previous one in its minor contribution of NK cells. Here T cells predominate the IFNgamma secretion. These results clearly demonstrate that the IFNgamma(+) subset distribution after VZAg-stimulation is not uniform and differs individually. Furthermore, the ISA-technology proves to be very useful in vaccine research. This was demonstrated by testing the IFNgamma(+) secretion pattern after HBsAg-stimulation in PBMC from HBsAg-vaccinated individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087231     DOI: 10.1016/j.jim.2004.01.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  Impact of T cell selection methods in the success of clinical adoptive immunotherapy.

Authors:  Natalia Ramírez; Lorea Beloki; Miriam Ciaúrriz; Mercedes Rodríguez-Calvillo; David Escors; Cristina Mansilla; Eva Bandrés; Eduardo Olavarría
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

2.  Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle.

Authors:  P Sopp; C J Howard; J C Hope
Journal:  Clin Vaccine Immunol       Date:  2006-09-27

3.  Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro.

Authors:  Lara Kristina Klauer; Olga Schutti; Selda Ugur; Fatemeh Doraneh-Gard; Daniel Christoph Amberger; Nicole Rogers; Doris Krämer; Andreas Rank; Christoph Schmid; Britta Eiz-Vesper; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2021-07-07       Impact factor: 3.747

4.  Rapid cloning of antigen-specific T-cell receptors by leveraging the cis activation of T cells.

Authors:  Eiji Kobayashi; Aishun Jin; Hiroshi Hamana; Kiyomi Shitaoka; Kazuto Tajiri; Seisuke Kusano; Shigeyuki Yokoyama; Tatsuhiko Ozawa; Tsutomu Obata; Atsushi Muraguchi; Hiroyuki Kishi
Journal:  Nat Biomed Eng       Date:  2022-04-07       Impact factor: 29.234

5.  Droplet encapsulation improves accuracy of immune cell cytokine capture assays.

Authors:  Yuan Yuan; Julie Brouchon; J Mauricio Calvo-Calle; Jing Xia; Li Sun; Xu Zhang; Kiera L Clayton; Fangfu Ye; David A Weitz; John A Heyman
Journal:  Lab Chip       Date:  2020-04-03       Impact factor: 6.799

6.  T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.

Authors:  Akiko Uenaka; Hisashi Wada; Midori Isobe; Takashi Saika; Kazuhide Tsuji; Eiichi Sato; Shuichiro Sato; Yuji Noguchi; Ryohei Kawabata; Takushi Yasuda; Yuichiro Doki; Hiromi Kumon; Keiji Iwatsuki; Hiroshi Shiku; Morito Monden; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric Hoffman; Lloyd J Old; Eiichi Nakayama
Journal:  Cancer Immun       Date:  2007-04-19

7.  Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.

Authors:  Manami Miyai; Shingo Eikawa; Akihiro Hosoi; Tamaki Iino; Hirokazu Matsushita; Midori Isobe; Akiko Uenaka; Heiichiro Udono; Jun Nakajima; Eiichi Nakayama; Kazuhiro Kakimi
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

8.  A Simple Microfluidic Platform for Long-Term Analysis and Continuous Dual-Imaging Detection of T-Cell Secreted IFN-γ and IL-2 on Antibody-Based Biochip.

Authors:  Dieudonné R Baganizi; Loïc Leroy; Loïc Laplatine; Stacie J Fairley; Samuel Heidmann; Samia Menad; Thierry Livache; Patrice N Marche; Yoann Roupioz
Journal:  Biosensors (Basel)       Date:  2015-12-04

9.  A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma.

Authors:  Hirokazu Matsushita; Yutaka Enomoto; Haruki Kume; Tohru Nakagawa; Hiroshi Fukuhara; Motofumi Suzuki; Tetsuya Fujimura; Yukio Homma; Kazuhiro Kakimi
Journal:  J Immunother Cancer       Date:  2014-08-19       Impact factor: 13.751

10.  Quantification and phenotypic characterisation of peripheral IFN-γ producing leucocytes in chickens vaccinated against Newcastle disease.

Authors:  S H Andersen; L Vervelde; K Sutton; L R Norup; E Wattrang; H R Juul-Madsen; T S Dalgaard
Journal:  Vet Immunol Immunopathol       Date:  2017-10-10       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.